# FDA Inspection 1154344 - Vitalant - September 24, 2021

Source: https://www.keypedia.com/records/fda_inspections/vitalant/9cc6f74e-cd89-4350-82b9-d55b40d52c99
Source feed: FDA_Inspections

> FDA Inspection 1154344 for Vitalant on September 24, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1154344
- Company Name: Vitalant
- Inspection Date: 2021-09-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1277492 - 2025-07-18](https://www.keypedia.com/records/fda_inspections/vitalant/99ec9e91-b9b1-4e99-8d38-485072ed18eb)
- [FDA Inspection 1277492 - 2025-07-18](https://www.keypedia.com/records/fda_inspections/vitalant/60137537-7f41-4665-ab37-3c277935373f)
- [FDA Inspection 1154344 - 2021-09-24](https://www.keypedia.com/records/fda_inspections/vitalant/39996387-111e-45d3-8d8c-70c0d53764d9)
- [FDA Inspection 1106094 - 2019-09-20](https://www.keypedia.com/records/fda_inspections/vitalant/39db97a4-cfd8-46a0-822c-2921380b6d07)
- [FDA Inspection 1011386 - 2017-05-08](https://www.keypedia.com/records/fda_inspections/vitalant/a36ac619-b859-4c68-b712-fc3d6afeb9a5)

Company: https://www.keypedia.com/companies/vitalant/5f6be220-1a80-43de-9256-9b844fee506a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d